Activated Protein C Ligation of Apoer2 (LRP8) Causes Dab1-Dependent Signaling in U937 Cells

Total Page:16

File Type:pdf, Size:1020Kb

Activated Protein C Ligation of Apoer2 (LRP8) Causes Dab1-Dependent Signaling in U937 Cells Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells Xia V. Yanga, Yajnavalka Banerjeea, Jose´ A. Ferna´ ndeza, Hiroshi Deguchia, Xiao Xua, Laurent O. Mosniera, Rolf. T. Urbanusb, Phillip G. de Grootb, Tara C. White-Adamsc, Owen J. T. McCartyc, and John H. Griffina,1 aDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037; bLaboratory of Clinical Chemistry and Haematology, University Medical Centre Utrecht, Utrecht, The Netherlands; and cDepartments of Biomedical Engineering and Cell and Developmental Biology, Oregon Health & Science University, Portland, OR 97239 Edited by Charles T. Esmon, Oklahoma Medical Research Foundation, Oklahoma City, OK, and approved November 18, 2008 (received for review August 2, 2008) Binding of activated protein C (APC) to cells triggers multiple ischemic stroke, NMDA excitotoxicity injury, and severe sepsis beneficial cytoprotective activities that suppress apoptosis, inflam- models (11–14) . mation, and endothelial barrier breakdown. One paradigm for Recently, two kinds of findings imply that the APC-EPCR- APC’s signaling emphasizes its binding to endothelial cell protein PAR1 paradigm is not always applicable and that alternative cell C receptor (EPCR) and subsequent protease activated receptor surface receptors might contribute to initiation of cell signaling (PAR)-1 activation. Here we used human monocytic-like U937 cells by APC. First, for a few in vitro assays of APC’s effects on certain to evaluate apolipoprotein E receptor 2 (ApoER2)-dependent sig- cells, it appeared that APC-initiated cell signaling did not naling by APC and found that APC initiated rapid phosphorylation require PAR1 (15, 16) or EPCR (17). Second, in a report of of Tyr-220 in the adaptor protein disabled-1 (Dab1) and of Ser-473 APC-platelet interactions, an important role was posited for in Akt. APC also induced phosphorylation of Ser-9 in glycogen APC binding to apolipoprotein E receptor-2 [ApoER2; aka LDL synthase kinase 3␤ (GSK3␤), which was blocked by the PI3K receptor (LDLR)-related protein 8; LRP8] (18) and to glycop- inhibitor LY294002. Receptor-associated protein (RAP), a general rotein Ib␣ (19). ApoER2 is a member of the LDLR family that antagonist for binding of ligands to LDL receptor family members, includes, among others, the LDLR, the LDLR related protein inhibited APC-induced phosphorylation of Dab1 and GSK3␤, (LRP), ApoER2, and the very low density lipoprotein receptor whereas anti-EPCR or anti-PAR1 blocking antibodies did not. (VLDLR) (20–23). Various LDLR family members provide Knocking down ApoER2 by using siRNA-ablated APC induced Dab1 major endocytotic activities for cells whereas other family mem- phosphorylation, suggesting that RAP-sensitive APC-induced sig- bers also play prominent roles for signal transduction. LDLR naling requires ApoER2. In surface plasmon resonance equilibrium family members can bind a spectrum of ligands on various cells, binding studies, APC bound with high affinity to soluble (s) ApoER2 not limited to lipoproteins, and ligation of many members of this (apparent Kd, Ϸ30 nM) but not to soluble very low density lipopro- receptor family suffices to initiate cell signaling. tein receptor. RAP blocked APC binding to sApoER2 but not to The physiologic neuronal Reelin signaling pathway involves sEPCR. RAP blocked binding of U937 cells to immobilized APC. RAP Reelin ligation of both ApoER2 and VLDLR and subsequent also blocked APC’s ability to inhibit endotoxin-induced tissue phosphorylation of the adaptor protein disabled-1 (Dab1) in- factor pro-coagulant activity of U937 cells. Thus, we propose that volving the Src family kinases Src and Fyn, followed by phos- ligation of ApoER2 by APC signals via Dab1 phosphorylation and phorylation of phosphatidylinositol 3-phosphate kinase (PI3K), subsequent activation of PI3K and Akt and inactivation of GSK3␤, Akt, and glycogen synthase kinase 3␤ (GSK3␤) (20–23). Re- thereby contributing to APC’s beneficial effects on cells. ceptor-associated protein (RAP) (24) is an antagonist for ApoER2 ligand binding that blocks Reelin’s effects on cells. endothelial protein C receptor ͉ reelin ͉ Akt ͉ PI3K ͉ monocyte Remarkably, murine genetic deficiencies of Reelin, ApoER2 plus VLDLR, Dab1, or Src plus Fyn produce mice with indis- ecombinant activated protein C (APC) reduces mortality in tinguishable phenotypes (reeler, scrambler, yotari) (22, 23, 25–29) Rsevere sepsis (1). APC, a well known plasma protein, can involving impaired motor coordination, compromised gait, trem- exert both anticoagulant and cytoprotective activities by dis- ors, and ataxia, plus abnormal patterns of neuronal positioning tinctly different mechanisms (2–4). Because two potent antico- in the brain. Moreover, reeler adult mice exhibit learning defects agulant plasma proteins, antithrombin and tissue factor pathway and have neurons with compromised long-term potentiation inhibitor, failed to reduce mortality in large phase III trials of functioning (30, 31). severe sepsis (5, 6), one may infer that one or more of APC’s Monocytic cell lines, such as the human leukemic monoblast cytoprotective actions contribute to mortality reduction by APC U937 cell line, have been used to study APC’s ability to modulate therapy. APC’s cytoprotective actions include inter alii anti-apo- monocyte apoptosis, phagocytosis, inflammation, and tissue ptotic and anti-inflammatory activities, alterations of gene ex- factor generation (4, 8, 32–34). To evaluate the potential rele- pression, pro-angiogenic activity, and endothelial barrier stabi- vance of ApoER2 for APC cell signaling mechanisms, APC- lization (4, 7, 8). initiated signaling in U937 cells was assayed based on the In vitro studies of the effects of APC on various cells support a paradigm for APC’s cell signaling based on two key receptors, Author contributions: X.V.Y., H.D., and J.H.G. designed research; X.V.Y., Y.B., J.A.F., H.D., endothelial protein C receptor (EPCR) (9) and the G protein- X.X., L.O.M., T.C.W.-A., and O.J.T.M. performed research; R.T.U. and P.G.d.G. contributed coupled receptor protease activated receptor-1 (PAR1) (10), new reagents/analytic tools; X.V.Y., Y.B., J.A.F., H.D., X.X., L.O.M., T.C.W.-A., and O.J.T.M. which mediate downstream cytoprotective effects (4). Central to analyzed data; and X.V.Y. and J.H.G. wrote the paper. this paradigm is the binding of APC’s ␥-carboxyglutamic acid- The authors declare no conflict of interest. rich N-terminal domain to the EPCR with subsequent cleavage This article is a PNAS Direct Submission. of PAR1 by APC’s protease domain, followed by PAR1-induced 1To whom correspondence should be addressed. E-mail: jgriffi[email protected]. direct effects of APC on cells. Strong support for the in vivo This article contains supporting information online at www.pnas.org/cgi/content/full/ relevance of this mechanism for triggering cell signaling by 0807594106/DCSupplemental. pharmacologic doses of APC comes from studies of murine © 2008 by The National Academy of Sciences of the USA 274–279 ͉ PNAS ͉ January 6, 2009 ͉ vol. 106 ͉ no. 1 www.pnas.org͞cgi͞doi͞10.1073͞pnas.0807594106 Downloaded by guest on September 25, 2021 hypothesis that APC ligation of ApoER2 would signal similarly to the Reelin signaling pathway wherein ApoER2 ligation by Reelin promotes signaling via phosphorylation of Dab1, which binds to an NPxY sequence of the intracellular C-terminal region of ApoER2 (21–23,26). Here we present data showing that APC binds to purified soluble (s) ApoER2, that U937 cells bind to immobilized APC, and that APC initiates RAP-sensitive phos- phorylation of Dab1 with consequent PI3K-dependent signaling via phosphorylations of Akt and GSK3␤. Our results indicate that APC initiates a Reelin-like signaling pathway and that ApoER2 should join EPCR and PAR1 as candidates for cell receptors or co-receptors that mediate APC’s cell signaling activities. Results U937 Cells Contain Two Forms of ApoER2. Because alternative splicing in various tissues determines the variable expression of ApoER2 in different tissues and different species (18, 35–38), we characterized the forms of ApoER2 mRNA in U937 cells [supporting information (SI) Fig. S1]. Two isoforms of ApoER2 were identified in U937 cells, both with deletions of exons 5 and 18 and one with an additional deletion of exon 15 that codes for the extracellular O-linked sugar region (Fig. S1C). APC Causes Phosphorylation of Dab1, Akt, and GSK3␤. Addition of APC to U937 cells caused phosphorylation of tyrosine residues in Dab1 within 10 min (Fig. 1A). Based on immunoblotting by using antibodies specific for pTyr220, APC caused phosphory- lation of Tyr-220 in Dab1 (data not shown). Phosphorylation of Tyr residues in Dab1 was not inhibited by a monoclonal antibody (RCR252) that blocks binding of APC to EPCR or by two anti-PAR1 monoclonal antibodies (ATAP2 and WEDE15) that block PAR1 signaling by APC. However, Dab1 phosphorylation was blocked by RAP, which blocks binding of ligands to LDLR family members such as ApoER2 (Fig. 1B). Knocking down Fig. 1. APC stimulates RAP-sensitive phosphorylation of Dab-1 and GSK-3␤. ApoER2 by using siRNA ablated APC-induced Dab1 phosphor- (A) Cells were incubated with or without APC (2 ␮g/mL) for 5 or 10 min at 37 °C. ylation (Fig. 2 A and B), indicating that ApoER2 is required for Dab1 was immunoprecipitated from cell lysates and was separated on SDS/ Dab1 phosphorylation under these conditions. Similar to the PAGE and blotted with anti-phosphorylated Tyr (␣-pY) or anti-Dab1 (␣-Dab1) Reelin signaling pathway that causes activation of Akt by phos- as described in Materials and Methods.(B) U937 cells were pre-treated with phorylation of Ser-473 (39, 40) downstream of Dab1 phosphor- control, anti-EPCR mAb RCR252 (15 ␮g/mL), RAP (2 ␮M), or anti-PAR1 anti- ylation, APC caused rapid phosphorylation of Ser-473 in Akt bodies (ATAP2 plus WEDE15, 15 ␮g/mL each) for 15 min, then incubated with ␮ (Fig.
Recommended publications
  • Cortical Layer V Neurons in the Auditory and Visual Cortices of Normal, Reeler, and Yotari Mice
    Kobe J. Med. Sci., Vol. 56, No. 2, pp. E50-E59, 2010 Cortical Layer V Neurons in the Auditory and Visual Cortices of Normal, reeler, and yotari Mice YASUO YOSHIHARA1, 2, TOMIYOSHI SETSU2, YU KATSUYAMA2, SATOSHI KIKKAWA2, TOSHIO TERASHIMA2*, and KIYOSHI MAEDA1 1Division of Psychiatry, 2Division of Anatomy and Developmental Neurobiology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan Received 19 January 2010/ Accepted 19 January 2010 Key Words: reeler, yotari, cortex, superior colliculus, inferior colliculus ABSTRACT Both in the Reelin-deficient reeler and Dab1-deficient yotari mice, layer V corticospinal tract neurons in the sensory-motor cortex are radially spread instead of being confined to a single cortical layer. In the present study, we examined distribution pattern of cortical layer V neurons in the visual and auditory cortices of reeler and yotari mice with the injection of HRP into the superior and inferior colliculi of the adult animals, respectively. After the injection of HRP into the superior colliculus of the normal mouse, retrogradely labeled cells were distributed in layer V of the visual cortex, while the similar injection of HRP in the reeler and yotari mice produced radial dispersion of retrograde labeling through all of the depths of the visual cortex of these mutant mice. Next, we injected HRP into the inferior colliculus of the normal, reeler and yotari mice. Retrogradely labeled neurons were distributed in layer V of the normal auditory cortex, whereas they were again radially scattered in the auditory cortex of the reeler and yotari mice. Taken together with the previous and present findings, layer V cortical efferent neurons are radially scattered in the sensory-motor, visual and auditory cortices of the reeler and yotari mice.
    [Show full text]
  • Identification of an Alpha-1 Antitrypsin Variant with Enhanced Specificity For
    www.nature.com/scientificreports OPEN Identifcation of an alpha‑1 antitrypsin variant with enhanced specifcity for factor XIa by phage display, bacterial expression, and combinatorial mutagenesis Varsha Bhakta1, Mostafa Hamada2, Amy Nouanesengsy2, Jessica Lapierre2, Darian L. Perruzza2 & William P. Shefeld1,2* Coagulation Factor XIa (FXIa) is an emerging target for antithrombotic agent development. The M358R variant of the serpin alpha‑1 antitrypsin (AAT) inhibits both FXIa and other proteases. Our aim was to enhance the specifcity of AAT M358R for FXIa. We randomized two AAT M358R phage display libraries at reactive centre loop positions P13‑P8 and P7‑P3 and biopanned them with FXIa. A bacterial expression library randomized at P2′‑P3′ was also probed. Resulting novel variants were expressed as recombinant proteins in E. coli and their kinetics of FXIa inhibition determined. The most potent FXIa‑inhibitory motifs were: P13‑P8, HASTGQ; P7‑P3, CLEVE; and P2‑P3′, PRSTE (respectively, novel residues bolded). Selectivity for FXIa over thrombin was increased up to 34‑fold versus AAT M358R for these single motif variants. Combining CLEVE and PRSTE motifs in AAT‑RC increased FXIa selectivity for thrombin, factors XIIa, Xa, activated protein C, and kallikrein by 279‑, 143‑, 63‑, 58‑, and 36‑fold, respectively, versus AAT M358R. AAT‑RC lengthened human plasma clotting times less than AAT M358R. AAT‑RC rapidly and selectively inhibits FXIa and is worthy of testing in vivo. AAT specifcity can be focused on one target protease by selection in phage and bacterial systems coupled with combinatorial mutagenesis. Trombosis, the blockage of intact blood vessels by occlusive clots, continues to impose a heavy clinical burden, and is responsible for one quarter of deaths world-wide1.
    [Show full text]
  • Reelin Is Preferentially Expressed in Neurons Synthesizing ␥-Aminobutyric Acid in Cortex and Hippocampus of Adult Rats
    Proc. Natl. Acad. Sci. USA Vol. 95, pp. 3221–3226, March 1998 Neurobiology Reelin is preferentially expressed in neurons synthesizing g-aminobutyric acid in cortex and hippocampus of adult rats C. PESOLD*†,F.IMPAGNATIELLO*, M. G. PISU*, D. P. UZUNOV*, E. COSTA*, A. GUIDOTTI*, AND H. J. CARUNCHO*‡ *Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612; and ‡Department of Morphological Sciences, University of Santiango de Compostela School of Medicine, 15705 Santiago de Compostela, Spain Contributed by Erminio Costa, December 24,1997 ABSTRACT During embryonic development of brain lam- sion, prevent Reelin transcription or secretion (4, 12, 14). In inated structures, the protein Reelin, secreted into the extracel- the cortex and hippocampus of rat embryos, Reelin begins to lular matrix of the cortex and hippocampus by Cajal–Retzius be synthesized in Cajal–Retzius (CR) cells from embryonic day (CR) cells located in the marginal zone, contributes to the 13 to the second postnatal week, and in the cerebellum Reelin regulation of migration and positioning of cortical and hip- is expressed first in the external granule cell layer (EGL) pocampal neurons that do not synthesize Reelin. Soon after before the granule cell migration to the internal granule cell birth, the CR cells decrease, and they virtually disappear during layer (IGL) (2, 15–17). When the CR50 antibody is added to the following 3 weeks. Despite their disappearance, we can embryonic preparations expressing normal histogenetic pat- quantify Reelin mRNA (approximately 200 amolymg of total terns of lamination, it induces typical histogenetic abnormal- RNA) and visualize it by in situ hybridization, and we detect the ities of the Relnrl phenotype (7, 9, 10, 17).
    [Show full text]
  • The VLDL Receptor Regulates Membrane Progesterone Receptor
    © 2018. Published by The Company of Biologists Ltd | Journal of Cell Science (2018) 131, jcs212522. doi:10.1242/jcs.212522 RESEARCH ARTICLE The VLDL receptor regulates membrane progesterone receptor trafficking and non-genomic signaling Nancy Nader, Maya Dib, Raphael Courjaret, Rawad Hodeify, Raya Machaca, Johannes Graumann and Khaled Machaca* ABSTRACT the plasma membrane and interact with the classical P4 receptor, is Progesterone mediates its physiological functions through activation of nonetheless effective at mediating non-genomic P4 signaling both transcription-coupled nuclear receptors and seven-pass- (Bandyopadhyay et al., 1998; Dressing et al., 2011; Peluso et al., transmembrane progesterone receptors (mPRs), which transduce 2002). These results argued for the presence of membrane P4 the rapid non-genomic actions of progesterone by coupling to various receptors that are distinct from the nuclear P4 receptors. In 2003, the signaling modules. However, the immediate mechanisms of action Thomas laboratory identified a family of membrane progesterone downstream of mPRs remain in question. Herein, we use an untargeted receptors (mPRs) from fish ovaries (Zhu et al., 2003a,b) that belong quantitative proteomics approach to identify mPR interactors to better to the progestin and adiponectin (AdipoQ) receptor family (also define progesterone non-genomic signaling. Surprisingly, we identify named PAQ receptors). However, the signal transduction cascade the very-low-density lipoprotein receptor (VLDLR) as an mPRβ downstream of mPRs that mediates the non-genomic actions of P4 (PAQR8) partner that is required for mPRβ plasma membrane remains unclear. localization. Knocking down VLDLR abolishes non-genomic The non-genomic action of mPR and the ensuing signaling progesterone signaling, which is rescued by overexpressing VLDLR.
    [Show full text]
  • Reelin Supplementation Into the Hippocampus Rescues Abnormal Behavior in a Mouse Model of Neurodevelopmental Disorders
    fncel-14-00285 August 31, 2020 Time: 14:32 # 1 ORIGINAL RESEARCH published: 02 September 2020 doi: 10.3389/fncel.2020.00285 Reelin Supplementation Into the Hippocampus Rescues Abnormal Behavior in a Mouse Model of Neurodevelopmental Disorders Daisuke Ibi1*†, Genki Nakasai1†, Nayu Koide1†, Masahito Sawahata2, Takao Kohno3, Rika Takaba1, Taku Nagai2,4, Mitsuharu Hattori3, Toshitaka Nabeshima5, Kiyofumi Yamada2* and Masayuki Hiramatsu1 1 Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 2 Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Japan, 3 Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan, 4 Project Office for Neuropsychological Research Center, Fujita Health University, Toyoake, Japan, 5 Advanced Diagnostic System Research Laboratory, Fujita Health University, Graduate School of Health Sciences, Toyoake, Japan Edited by: Marie-Eve Tremblay, In the majority of schizophrenia patients, chronic atypical antipsychotic administration University of Victoria, Canada produces a significant reduction in or even complete remission of psychotic symptoms Reviewed by: such as hallucinations and delusions. However, these drugs are not effective in Dilja Krueger-Burg, improving cognitive and emotional deficits in patients with schizophrenia. Atypical University Medical Center Göttingen, Germany antipsychotic drugs have a high affinity for the dopamine D2 receptor, and a José M. Delgado-García,
    [Show full text]
  • Protein Interaction Network of Alternatively Spliced Isoforms from Brain Links Genetic Risk Factors for Autism
    ARTICLE Received 24 Aug 2013 | Accepted 14 Mar 2014 | Published 11 Apr 2014 DOI: 10.1038/ncomms4650 OPEN Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism Roser Corominas1,*, Xinping Yang2,3,*, Guan Ning Lin1,*, Shuli Kang1,*, Yun Shen2,3, Lila Ghamsari2,3,w, Martin Broly2,3, Maria Rodriguez2,3, Stanley Tam2,3, Shelly A. Trigg2,3,w, Changyu Fan2,3, Song Yi2,3, Murat Tasan4, Irma Lemmens5, Xingyan Kuang6, Nan Zhao6, Dheeraj Malhotra7, Jacob J. Michaelson7,w, Vladimir Vacic8, Michael A. Calderwood2,3, Frederick P. Roth2,3,4, Jan Tavernier5, Steve Horvath9, Kourosh Salehi-Ashtiani2,3,w, Dmitry Korkin6, Jonathan Sebat7, David E. Hill2,3, Tong Hao2,3, Marc Vidal2,3 & Lilia M. Iakoucheva1 Increased risk for autism spectrum disorders (ASD) is attributed to hundreds of genetic loci. The convergence of ASD variants have been investigated using various approaches, including protein interactions extracted from the published literature. However, these datasets are frequently incomplete, carry biases and are limited to interactions of a single splicing isoform, which may not be expressed in the disease-relevant tissue. Here we introduce a new interactome mapping approach by experimentally identifying interactions between brain-expressed alternatively spliced variants of ASD risk factors. The Autism Spliceform Interaction Network reveals that almost half of the detected interactions and about 30% of the newly identified interacting partners represent contribution from splicing variants, emphasizing the importance of isoform networks. Isoform interactions greatly contribute to establishing direct physical connections between proteins from the de novo autism CNVs. Our findings demonstrate the critical role of spliceform networks for translating genetic knowledge into a better understanding of human diseases.
    [Show full text]
  • The Reeler Mouse: a Translational Model of Human 3 Neurological Conditions Or Simply a Good Tool for 4 Better Understanding Neurodevelopment?
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 10 October 2019 doi:10.20944/preprints201910.0120.v1 Peer-reviewed version available at J. Clin. Med. 2019, 8, 2088; doi:10.3390/jcm8122088 1 Review 2 The Reeler Mouse: A Translational Model of Human 3 Neurological Conditions or Simply a Good Tool for 4 Better Understanding Neurodevelopment? 5 6 7 Laura Lossi 1, Claudia Castagna2, Alberto Granato3*, and Adalberto Merighi4* 8 1 Department of Veterinary Sciences, University of Turin, Grugliasco (TO) I-10095, Italy. [email protected] 9 2 Department of Veterinary Sciences, University of Turin, Grugliasco (TO) I-10095, Italy. 10 [email protected] 11 3 Department of Psychology, Catholic University of the Sacred Heart, Milano (MI) I-20123, Italy. 12 [email protected] 13 4 Department of Veterinary Sciences, University of Turin, Grugliasco (TO) I-10095, Italy. 14 [email protected] 15 16 * Correspondence: [email protected], Tel ++39. 02.7234.8588; [email protected] , Tel.: 17 ++39.011.670.9118 18 19 Abstract: 20 The Reeler mutation was described in mouse more than fifty years ago. Later, its causative gene 21 (reln) was discovered in mouse, and its human orthologue (RELN) was demonstrated to be 22 causative of lissencephaly 2 (LIS2) and about 20% of the cases of autosomal-dominant lateral 23 temporal epilepsy (ADLTE). In both human and mice the gene encodes for a glycoprotein referred 24 to as Reelin (Reln) that plays a primary role in neuronal migration during development and 25 synaptic stabilization in adulthood. Besides LIS2 and ADLTE, RELN and/or other genes coding for 26 the proteins of the Reln intracellular cascade have been associated more or less substantially to 27 other conditions such as spinocerebellar ataxia type 7 and 37, VLDLR-associated cerebellar 28 hypoplasia, PAFAH1B1-associated lissencephaly, autism and schizophrenia.
    [Show full text]
  • Clinical Study High Complement Factor I Activity in the Plasma of Children with Autism Spectrum Disorders
    Hindawi Publishing Corporation Autism Research and Treatment Volume 2012, Article ID 868576, 6 pages doi:10.1155/2012/868576 Clinical Study High Complement Factor I Activity in the Plasma of Children with Autism Spectrum Disorders Naghi Momeni,1 Lars Brudin,2 Fatemeh Behnia,3 Berit Nordstrom,¨ 4 Ali Yosefi-Oudarji,5 Bengt Sivberg,4 Mohammad T. Joghataei,5 and Bengt L. Persson1 1 School of Natural Sciences, Linnaeus University, 39182 Kalmar, Sweden 2 Department of Clinical Physiology, Kalmar County Hospital, 39185 Kalmar, Sweden 3 Department of Occupational Therapy, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran 4 Department of Health Sciences, Autism Research, Faculty of Medicine, Lund University, Box 157, 22100 Lund, Sweden 5 Cellular and Molecular Research Centre, Tehran University of Medical Sciences (TUMS), Tehran, Iran Correspondence should be addressed to Bengt Sivberg, [email protected] Received 17 June 2011; Revised 22 August 2011; Accepted 22 August 2011 Academic Editor: Judy Van de Water Copyright © 2012 Naghi Momeni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Autism spectrum disorders (ASDs) are neurodevelopmental and behavioural syndromes affecting social orientation, behaviour, and communication that can be classified as developmental disorders. ASD is also associated with immune system abnormality. Im- mune system abnormalities may be caused partly by complement system factor I deficiency. Complement factor I is a serine pro- tease present in human plasma that is involved in the degradation of complement protein C3b, which is a major opsonin of the complement system.
    [Show full text]
  • Gene Expression of Prohormone and Proprotein Convertases in the Rat CNS: a Comparative in Situ Hybridization Analysis
    The Journal of Neuroscience, March 1993. 73(3): 1258-1279 Gene Expression of Prohormone and Proprotein Convertases in the Rat CNS: A Comparative in situ Hybridization Analysis Martin K.-H. Schafer,i-a Robert Day,* William E. Cullinan,’ Michel Chri?tien,3 Nabil G. Seidah,* and Stanley J. Watson’ ‘Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan 48109-0720 and J. A. DeSeve Laboratory of *Biochemical and 3Molecular Neuroendocrinology, Clinical Research Institute of Montreal, Montreal, Quebec, Canada H2W lR7 Posttranslational processing of proproteins and prohor- The participation of neuropeptides in the modulation of a va- mones is an essential step in the formation of bioactive riety of CNS functions is well established. Many neuropeptides peptides, which is of particular importance in the nervous are synthesized as inactive precursor proteins, which undergo system. Following a long search for the enzymes responsible an enzymatic cascade of posttranslational processing and mod- for protein precursor cleavage, a family of Kexin/subtilisin- ification events during their intracellular transport before the like convertases known as PCl, PC2, and furin have recently final bioactive products are secreted and act at either pre- or been characterized in mammalian species. Their presence postsynaptic receptors. Initial endoproteolytic cleavage occurs in endocrine and neuroendocrine tissues has been dem- C-terminal to pairs of basic amino acids such as lysine-arginine onstrated. This study examines the mRNA distribution of (Docherty and Steiner, 1982) and is followed by the removal these convertases in the rat CNS and compares their ex- of the basic residues by exopeptidases. Further modifications pression with the previously characterized processing en- can occur in the form of N-terminal acetylation or C-terminal zymes carboxypeptidase E (CPE) and peptidylglycine a-am- amidation, which is essential for the bioactivity of many neu- idating monooxygenase (PAM) using in situ hybridization ropeptides.
    [Show full text]
  • Thalamocortical Development: How Are We Going to Get There?
    REVIEWS THALAMOCORTICAL DEVELOPMENT: HOW ARE WE GOING TO GET THERE? Guillermina López-Bendito and Zoltán Molnár The arealization of the mammalian cortex is believed to be controlled by a combination of intrinsic factors that are expressed in the cortex, and external signals, some of which are mediated through thalamic input. Recent studies on transgenic mice have identified families of molecules that are involved in thalamic axon growth, pathfinding and cortical target selection, and we are beginning to understand how thalamic projections impose cytoarchitectonic differentiation on the developing cortex. By unravelling these mechanisms further, we should be able to increase our understanding of the principles of cortical organization. EPIGENETIC The mechanisms that control neocortical regionaliza- each area send corticofugal projections back to the Describes a change in tion — or arealization — have been the subject of much corresponding thalamic nucleus, and layer V sends phenotype that is brought about debate. Intrinsic mechanisms, such as differential gene projections to additional nuclei4 (FIG. 1c). by changes in the regulation of expression that is autonomous to the neocortex, and This article provides an overview of the exciting gene expression or changes in the function of gene products, extrinsic influences, such as input from thalamocortical recent progress that has been made in the field of thala- rather than by a change in afferents, have both gained support from recent mocortical development. The transgenic mouse has genotype. studies1. Although some components of local special- proved to be a very powerful tool to increase our under- ization are determined by differential patterns of com- standing of the principal developmental mechanisms, VENTRICULAR ZONE The proliferative inner layer mitment at an early stage of development (perhaps and it has helped us to dissect the causal relationships of the developing brain and even during mitosis), there is considerable evidence that between thalamocortical fibre targeting and areal spinal cord.
    [Show full text]
  • Contribution of Multiple Inherited Variants to Autism Spectrum Disorder (ASD) in a Family with 3 Affected Siblings
    G C A T T A C G G C A T genes Article Contribution of Multiple Inherited Variants to Autism Spectrum Disorder (ASD) in a Family with 3 Affected Siblings Jasleen Dhaliwal 1 , Ying Qiao 1,2, Kristina Calli 1,2, Sally Martell 1,2, Simone Race 3,4,5, Chieko Chijiwa 1,5, Armansa Glodjo 3,5, Steven Jones 1,6 , Evica Rajcan-Separovic 2,7, Stephen W. Scherer 4 and Suzanne Lewis 1,2,5,* 1 Department of Medical Genetics, University of British Columbia (UBC), Vancouver, BC V6H 3N1, Canada; [email protected] (J.D.); [email protected] (Y.Q.); [email protected] (K.C.); [email protected] (S.M.); [email protected] (C.C.); [email protected] (S.J.) 2 BC Children’s Hospital, Vancouver, BC V5Z 4H4, Canada; [email protected] 3 Department of Pediatrics, University of British Columbia (UBC), Vancouver, BC V6T 1Z7, Canada; [email protected] (S.R.); [email protected] (A.G.) 4 The Centre for Applied Genomics and McLaughlin Centre, Hospital for Sick Children and University of Toronto, Toronto, ON M5G 0A4, Canada; [email protected] 5 BC Children’s and Women’s Health Center, Vancouver, BC V6H 3N1, Canada 6 Michael Smith Genome Sciences Centre, Vancouver, BC V5Z 4S6, Canada 7 Department of Pathology and Laboratory Medicine, University of British Columbia (UBC), Vancouver, BC V6T 1Z7, Canada * Correspondence: [email protected] Abstract: Autism Spectrum Disorder (ASD) is the most common neurodevelopmental disorder in Citation: Dhaliwal, J.; Qiao, Y.; Calli, children and shows high heritability.
    [Show full text]
  • Proquest Dissertations
    urn u Ottawa L'Universitd canadienne Canada's university FACULTE DES ETUDES SUPERIEURES l^^l FACULTY OF GRADUATE AND ET POSTDOCTORALES u Ottawa POSTDOCTORAL STUDIES I.'University emiadienne Canada's university Charles Gyamera-Acheampong AUTEUR DE LA THESE / AUTHOR OF THESIS Ph.D. (Biochemistry) GRADE/DEGREE Biochemistry, Microbiology and Immunology FACULTE, ECOLE, DEPARTEMENT / FACULTY, SCHOOL, DEPARTMENT The Physiology and Biochemistry of the Fertility Enzyme Proprotein Convertase Subtilisin/Kexin Type 4 TITRE DE LA THESE / TITLE OF THESIS M. Mbikay TIRECTWRTDIRICTR^ CO-DIRECTEUR (CO-DIRECTRICE) DE LA THESE / THESIS CO-SUPERVISOR EXAMINATEURS (EXAMINATRICES) DE LA THESE/THESIS EXAMINERS A. Basak G. Cooke F .Kan V. Mezl Gary W. Slater Le Doyen de la Faculte des etudes superieures et postdoctorales / Dean of the Faculty of Graduate and Postdoctoral Studies Library and Archives Bibliotheque et 1*1 Canada Archives Canada Published Heritage Direction du Branch Patrimoine de I'edition 395 Wellington Street 395, rue Wellington OttawaONK1A0N4 Ottawa ON K1A 0N4 Canada Canada Your file Votre reference ISBN: 978-0-494-59504-6 Our file Notre reference ISBN: 978-0-494-59504-6 NOTICE: AVIS: The author has granted a non­ L'auteur a accorde une licence non exclusive exclusive license allowing Library and permettant a la Bibliotheque et Archives Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par telecommunication ou par I'lnternet, prefer, telecommunication or on the Internet, distribuer et vendre des theses partout dans le loan, distribute and sell theses monde, a des fins commerciales ou autres, sur worldwide, for commercial or non­ support microforme, papier, electronique et/ou commercial purposes, in microform, autres formats.
    [Show full text]